Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapering Methotrexate in RA Patients on Tocilizumab
NCT01661140Phase 4Terminated
- Sponsor
- Roche
- Start
- Sep 2012
- Primary completion
- Feb 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tocilizumab in rheumatoid arthritis (RA) (2 arms), sponsored by Roche. Primary endpoint: Percentage of Participants Maintaining Previous Disease Activity (European League Against Rheumatism [EULAR] Response). Started Sep 2012; status: terminated.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01661140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01661140.